H. Nelson

发表

Bifunctional antibody retargeting in vivo-activated T lymphocytes: simplifying clinical application.

A. Chapoval, H. Nelson, C. Thibault, 1995, Journal of hematotherapy.

Antibody to ras proteins in patients with colon cancer.

D. Byrd, L. McCahill, M. Takahashi, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pulmonary metastases neutralization and tumor rejection by in vivo administration of β glucan and bispecific antibody

H. Nelson, C. Penna, P. Dean, 1996, International journal of cancer.

Tumor‐infiltrating lymphocytes can be activated in situ by using in vivo activants plus F(ab′)2 bispecific antibodies

A. Chapoval, H. Nelson, C. Thibault, 1996, International journal of cancer.

Anti-tumor x anti-CD3 heteroconjugates direct human peripheral blood lymphocytes to lyse colon tumor cells.

D. McKean, H. Nelson, J. Donohue, 1990, The Journal of surgical research.

Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.

D. McKean, H. Nelson, P. Ramsey, 1990, Journal of immunology.

Interferon-T-induced Intercellular Adhesion Molecule-l: Expression on Human Tumor Cells Enhances Bifunctional Antibody-mediated Lysis through a Lymphocyte Function-associated Antigen-I Dependent Mechanism I

H. Nelson, P. Dean, P. Ramsey, 2007 .

Interferon-γ-induced Intercellular Adhesion Molecule-1: Expression on Human Tumor Cells Enhances Bifunctional Antibody-mediated Lysis through a Lymphocyte Function-associated Antigen-1 Dependent Mechanism

H. Nelson, P. Dean, P. Ramsey, 1993 .

Heteroconjugated antibodies enhance lymphocyte‐mediated tumour cell lysis in vitro and in vivo

J. Monson, J. Donohue, D. Ilstrup, 1992, The British journal of surgery.

Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases.

H. Nelson, C. Penna, P. Dean, 1994, Cancer research.

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.

Wei Chen, D. Peace, M. Cheever, 1991, Journal of immunology.

Microvascular expression of mala‐2 correlates with In vivo lymphocyte trafficking and is preferentially enhanced in tumors by tumor necrosis factor‐α and interleukin‐1α

H. Nelson, P. Dean, P. Ramsey, 1994, International journal of cancer.

Anti-tumor × anti-lymphocyte heteroconjugates augment colon tumor cell lysisin Vitro and prevent tumor growthin Vivo

J. Donohue, H. Nelson, P. Ramsey, 1991 .

Interferon-gamma-induced intercellular adhesion molecule-1: expression on human tumor cells enhances bifunctional antibody-mediated lysis through a lymphocyte function-associated antigen-1 dependent mechanism.

H. Nelson, P. Dean, P. Ramsey, 1993, Cancer Research.

Targeted cellular immunotherapy with bifunctional antibodies.

H. Nelson, 1991, Cancer cells.

Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.

A. Chapoval, H. Nelson, C. Thibault, 1995, Journal of immunology.

Cell adhesion molecule expression within the microvasculature of human colorectal malignancies.

L. Wold, H. Nelson, P. Ramsey, 1994, Clinical Immunology and Immunopathology.